LATISSE®

Data on thinning lashes!
You may be surprised to know that published expert opinions have linked thinning and loss of eyelashes to aging.1,2 This finding led Allergan to analyze the photos of a subset of women with inadequate or not enough lashes pooled from three LATISSE® clinical trials. The results revealed that the older women had thinner, shorter and lighter lashes at week 0, compared to the younger women in the trials. The demographic data suggests there may be a downward trend of eyelash fullness, length and darkness as women with inadequate lashes age.2

Take a moment to assess your lashes.
Perhaps you’ve noticed a change in your lashes over the years. Have they lost their fullness? Do they appear shorter? Or lighter in color? If so, it’s time to consider LATISSE® – the only FDA-approved product that grows lashes, increasing their overall prominence. Ask your doctor if LATISSE® is right for you.

LATISSE® can grow thinning lashes.
In the US Phase III LATISSE® clinical trial, 91% of women participating (n=134) were 35 or older2, and results show that LATISSE® more than doubled lash fullness after 16 weeks of treatment for these patients.

lattisse

LATISSE® (bimatoprost ophthalmic solution) 0.03% Important Information
Indication
LATISSE® is a prescription treatment for hypotrichosis (inadequate or not enough lashes) to grow eyelashes longer, fuller, darker.
Important Safety Information
If you use/used prescription products for eye pressure problems, use LATISSE® under doctor care. LATISSE® may cause increased brown pigmentation of the colored part of the eye which is likely permanent. Eyelid skin darkening may occur and may be reversible. Only apply at the base of upper lashes. DO NOT APPLY to lower lid. Hair may grow on skin that LATISSE® frequently touches. If you have eye problems/surgery, consult your doctor about use of LATISSE®. Common side effects are itchy and red eyes. If discontinued, lashes gradually return to previous appearance.You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click here for full LATISSE® Prescribing Information.